Ontario Clinical Oncology Group (ocog)

This study tests a drug called elranatamab in people with multiple myeloma that has come back or stopped responding to at least three prior treatments. The goal is to see if giving the drug in an outpatient setting with breaks between doses can reduce side effects and hospital st…

This study is for women with early-stage breast cancer that has not spread to lymph nodes. After chemotherapy and lumpectomy (surgery to remove the tumor), if the cancer is completely gone, researchers want to see if it is safe to skip radiation therapy. The goal is to avoid the …

This study looks at men whose prostate cancer has come back in a few spots after radiation therapy. It compares two approaches: targeted treatment alone versus targeted treatment plus a hormone-blocking drug (ELIGARD). The goal is to see which combination delays cancer progressio…

This study compares a 1-week course of partial breast radiation to standard whole breast radiation in women with early-stage breast cancer. The goal is to see if the shorter treatment is just as effective at preventing cancer from coming back and causes fewer cosmetic side effect…

This study looks at whether women over 45 with a low-risk type of early breast cancer called DCIS can avoid radiation after surgery. Doctors use a genetic test (Oncotype DX) along with other factors to identify those with a very low chance of the cancer coming back. The goal is t…